Sol-Gel Technologies, Ltd.

/Sol-Gel Technologies, Ltd.

They are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases

Symbol

Price Range
TBD

Anticipated Shares
6,250,000

Effective Date
February 1, 2018

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange